| scholarly article | Q13442814 |
| P50 | author | Dipshikha Chakravortty | Q47494288 |
| P2093 | author name string | Vidya Devi Negi | |
| Priya DasSarma | |||
| Shiladitya DasSarma | |||
| Ram Karan | |||
| Arjun Balakrishnan | |||
| Susan Barnes | |||
| Folasade Ekulona | |||
| P2860 | cites work | Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid | Q22122046 |
| Complete genome sequence of Salmonella enterica serovar Typhimurium LT2 | Q22122369 | ||
| Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18 | Q22122370 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| A mouse model of Salmonella typhi infection | Q24610761 | ||
| IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation | Q24629447 | ||
| Bioengineering radioresistance by overproduction of RPA, a mammalian-type single-stranded DNA-binding protein, in a halophilic archaeon | Q28655746 | ||
| A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice | Q28748972 | ||
| The global burden of typhoid fever | Q29619215 | ||
| Identification of a common immune signature in murine and human systemic Salmonellosis | Q30424877 | ||
| Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea | Q30842030 | ||
| Subunit structure of gas vesicles: a MALDI-TOF mass spectrometry study | Q33196247 | ||
| Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle | Q33317659 | ||
| Short-term signatures of evolutionary change in the Salmonella enterica serovar typhimurium 14028 genome | Q33586060 | ||
| SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation | Q33636080 | ||
| High-frequency mutations in a plasmid-encoded gas vesicle gene in Halobacterium halobium | Q33648424 | ||
| Understanding the adaptation of Halobacterium species NRC-1 to its extreme environment through computational analysis of its genome sequence | Q34094195 | ||
| Nontyphoidal salmonellosis | Q34136663 | ||
| An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from Haloarchaea. | Q34393453 | ||
| Cloning, overexpression, purification, and characterization of a polyextremophilic β-galactosidase from the Antarctic haloarchaeon Halorubrum lacusprofundi | Q34548717 | ||
| Historical insights into cytokines | Q34708047 | ||
| Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. | Q34740218 | ||
| Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. | Q34975385 | ||
| The rightward gas vesicle operon in Halobacterium plasmid pNRC100: identification of the gvpA and gvpC gene products by use of antibody probes and genetic analysis of the region downstream of gvpC. | Q35966873 | ||
| Wild-type gas vesicle formation requires at least ten genes in the gvp gene cluster of Halobacterium halobium plasmid pNRC100 | Q35983916 | ||
| International Salmonella Typhimurium DT104 infections, 1992-2001 | Q36009448 | ||
| Salmonella effectors: important players modulating host cell function during infection | Q36054725 | ||
| Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials | Q36967461 | ||
| Complexity of gas vesicle biogenesis in Halobacterium sp. strain NRC-1: identification of five new proteins | Q37735317 | ||
| In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system | Q37848363 | ||
| The Th1 life cycle: molecular control of IFN-γ to IL-10 switching | Q37870570 | ||
| Cellular and organellar membrane-associated proteins in haloarchaea: perspectives on the physiological significance and biotechnological applications | Q38014379 | ||
| Vaccines for typhoid fever and other salmonelloses | Q38028786 | ||
| Targeting the "cytokine storm" for therapeutic benefit | Q38071254 | ||
| Prospects for prevention of Salmonella infection in children through vaccination | Q38099531 | ||
| Prevalence and genetic analysis of phenotypically Vi- negative Salmonella typhi isolates in children from Kathmandu, Nepal | Q40250722 | ||
| Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice | Q40387427 | ||
| Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. | Q40446943 | ||
| Genetic transformation of a halophilic archaebacterium with a gas vesicle gene cluster restores its ability to float | Q43016485 | ||
| Antigen presentation using novel particulate organelles from halophilic archaea | Q43028911 | ||
| SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria | Q47840879 | ||
| Post-genomics of the model haloarchaeon Halobacterium sp. NRC-1 | Q57103308 | ||
| Typhoid vaccines | Q74275506 | ||
| Typhoid vaccines: WHO position paper | Q80660808 | ||
| New structural proteins of Halobacterium salinarum gas vesicle revealed by comparative proteomics analysis | Q82889160 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 4543-4549 | |
| P577 | publication date | 2014-06-17 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria | |
| P478 | volume | 32 |
| Q36868095 | Bioengineering novel floating nanoparticles for protein and drug delivery |
| Q26782563 | Gas Vesicle Nanoparticles for Antigen Display |
| Q30411190 | Haloarchaea and the formation of gas vesicles |
| Q34515009 | Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development |
| Q37267087 | Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock |
| Q36160348 | Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles |
| Q40131248 | Molecular genetic and physical analysis of gas vesicles in buoyant enterobacteria |
| Q39373957 | Vaccination against Salmonella Infection: the Mucosal Way. |
Search more.